Registration Dossier

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
weight of evidence
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
data from handbook or collection of data

Data source

Reference
Reference Type:
review article or handbook
Title:
Acetoxolone Tox Acute
Author:
Canadian Centre for Occupational health and Safety
Year:
2018
Bibliographic source:
RTECS number RK0177570

Materials and methods

Test guideline
Guideline:
other: Method not published
Principles of method if other than guideline:
Animals were treatment with the test material at different dosages and the mortality evaluated.
GLP compliance:
not specified
Test type:
other: not reported

Test material

Constituent 1
Chemical structure
Reference substance name:
(3β,20β)-3-acetoxy-11-oxoolean-12-en-29-oic acid
EC Number:
228-475-1
EC Name:
(3β,20β)-3-acetoxy-11-oxoolean-12-en-29-oic acid
Cas Number:
6277-14-1
Molecular formula:
C32H48O5
IUPAC Name:
(2S,4aS,6aR,6aS,6bR,8aR,10S,12aS,14bR)-10-acetyloxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1H-picene-2-carboxylic acid
Test material form:
solid

Test animals

Species:
rat
Strain:
not specified
Sex:
not specified

Administration / exposure

Route of administration:
oral: unspecified
Vehicle:
not specified

Results and discussion

Effect levels
Sex:
not specified
Dose descriptor:
LD50
Effect level:
> 3 300 mg/kg bw
Based on:
test mat.
Clinical signs:
Details of toxic effects not reported other than lethal dose value

Applicant's summary and conclusion

Interpretation of results:
Category 5 based on GHS criteria